Law Firm Probes Option Care Health Over Shareholder Rights
Monteverde & Associates is investigating Option Care Health amid potential M&A concerns. The firm has recovered millions for shareholders in past cases.
A New York-based securities law firm has opened an investigation into Option Care Health, Inc. (NASDAQ: OPCH), scrutinizing whether the home infusion therapy company's board has adequately protected shareholder interests, according to an announcement released Oct. 11, 2026.
Monteverde & Associates PC, led by class action attorney Juan Monteverde, is behind the probe. The firm describes itself as a specialist in merger-and-acquisition litigation and has been recognized as a Top 50 firm in the 2025 ISS Securities Class Action Services Report, a widely referenced industry ranking.
Read more Long-Term Uranium Price Tops 2007 Record at $96.50 Per Pound →
The firm states it has recovered millions of dollars for shareholders in prior cases, though no specific figures related to the Option Care Health matter were disclosed in the announcement. No lawsuit has been filed at this stage; the firm is soliciting contact from current OPCH shareholders who may wish to learn more about their legal options.
Investigations of this type typically precede potential class action lawsuits and often center on whether a company's directors fulfilled their fiduciary duties in connection with a pending or completed transaction. Option Care Health is a major provider of home and alternate-site infusion services across the United States.
Shareholders with questions about the investigation are encouraged to contact Monteverde & Associates directly. Continue reading at All Financial Services & Investing.
